Jody A. Charnow

Editor https://www.cancertherapyadvisor.com

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

Investigators found that PSA testing may be a poor surrogate for patient outcome in the contemporary

Prostate Cancer

Higher Radiation Dose Key to Better Brachytherapy Outcomes

Jody A. Charnow

May 10, 2016

Higher radiation doses are critical to optimizing long-term outcomes following brachytherapy for prostate cancer (PCa).

Urologic Cancers

Bladder Cancer Risk Higher Following Prostate Radiotherapy

Jody A. Charnow

May 10, 2016

Prostate cancer patients who undergo radiation treatment, especially brachytherapy, are at increased relative risk of bladder cancer.

Bilateral orchiectomy is as effective as gonadotropin-releasing hormone agonists in controlling pros

Prostate Cancer

Long-Term Radical Prostatectomy Outcomes Better for cT1a Prostate Cancer

Jody A. Charnow

May 10, 2016

Patients with cT1a and cT1b prostate tumors have favorable long-term outcomes after radical prostatectomy (RP).

Prostate Cancer

Baseline PSA at Age 55-60 Predicts Risk for Prostate Cancer

Jody A. Charnow

May 10, 2016

Baseline PSA levels in men aged 55-60 years strongly predict the future risk of being diagnosed with prostate cancer (PCa).

Dose-intensified salvage radiation therapy was associated with low rates of acute toxicity and minim

Prostate Cancer

Poverty Linked With High-risk Prostate Cancer

Jody A. Charnow

May 10, 2016

Poverty is associated with an increased risk of advanced stage or aggressive prostate cancer (PCa), regardless of race.

The link between lifestyle and colorectal cancer has been increasingly studied, highlighting the pot

Prostate Cancer

Low-Carb Diet May Curb Adverse Effects of Prostate Cancer ADT

Jody A. Charnow

May 10, 2016

Carbohydrate restriction may be effective in ameliorating adverse effects associated with androgen-deprivation therapy (ADT) for prostate cancer.

A substantial proportion of patients with rectal cancer managed by the watch-and-wait approach avoid

Prostate Cancer

Salvage Radical Prostatectomy Offers Good Long-Term Outcomes

Jody A. Charnow

May 9, 2016

Salvage radical prostatectomy (SRP) offers good long-term oncologic outcomes among patients who experience recurrence.

Dr Neal Shore spoke with Cancer Therapy Advisor about the place of radium-223 in the therapeutic arm

Prostate Cancer

Dr Neal Shore: Novel Approaches to Using Radium-223

Jody A. Charnow

April 1, 2016

Dr Neal Shore spoke with Cancer Therapy Advisor about the place of radium-223 in the therapeutic armamentarium and how he uses the drug in his practice.